Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation

The alpha subunit of IL-7 receptor (IL7R7α) is critical for the differentiation of T cells, specifically for the development and maintenance of γδT cells. Mutations in IL7RA are associated with Severe Combined Immunodeficiency (SCID). Infants with IL7RA deficiency can be identified through newborn s...

Full description

Bibliographic Details
Main Authors: Atar Lev, Amos J. Simon, Ortal Barel, Eran Eyal, Efrat Glick-Saar, Omri Nayshool, Ohad Birk, Tali Stauber, Amit Hochberg, Arnon Broides, Shlomo Almashanu, Ayal Hendel, Yu Nee Lee, Raz Somech
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Immunology
Subjects:
PID
NBS
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01672/full
id doaj-f599f85fc3684f1b96df701ade6f8c09
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Atar Lev
Atar Lev
Amos J. Simon
Amos J. Simon
Ortal Barel
Ortal Barel
Eran Eyal
Eran Eyal
Eran Eyal
Efrat Glick-Saar
Efrat Glick-Saar
Efrat Glick-Saar
Omri Nayshool
Omri Nayshool
Omri Nayshool
Ohad Birk
Tali Stauber
Amit Hochberg
Arnon Broides
Shlomo Almashanu
Ayal Hendel
Yu Nee Lee
Yu Nee Lee
Raz Somech
Raz Somech
spellingShingle Atar Lev
Atar Lev
Amos J. Simon
Amos J. Simon
Ortal Barel
Ortal Barel
Eran Eyal
Eran Eyal
Eran Eyal
Efrat Glick-Saar
Efrat Glick-Saar
Efrat Glick-Saar
Omri Nayshool
Omri Nayshool
Omri Nayshool
Ohad Birk
Tali Stauber
Amit Hochberg
Arnon Broides
Shlomo Almashanu
Ayal Hendel
Yu Nee Lee
Yu Nee Lee
Raz Somech
Raz Somech
Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation
Frontiers in Immunology
IIL7Rα
PID
SCID
NBS
TREC
immune repertoire
author_facet Atar Lev
Atar Lev
Amos J. Simon
Amos J. Simon
Ortal Barel
Ortal Barel
Eran Eyal
Eran Eyal
Eran Eyal
Efrat Glick-Saar
Efrat Glick-Saar
Efrat Glick-Saar
Omri Nayshool
Omri Nayshool
Omri Nayshool
Ohad Birk
Tali Stauber
Amit Hochberg
Arnon Broides
Shlomo Almashanu
Ayal Hendel
Yu Nee Lee
Yu Nee Lee
Raz Somech
Raz Somech
author_sort Atar Lev
title Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation
title_short Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation
title_full Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation
title_fullStr Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation
title_full_unstemmed Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation
title_sort reduced function and diversity of t cell repertoire and distinct clinical course in patients with il7ra mutation
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2019-07-01
description The alpha subunit of IL-7 receptor (IL7R7α) is critical for the differentiation of T cells, specifically for the development and maintenance of γδT cells. Mutations in IL7RA are associated with Severe Combined Immunodeficiency (SCID). Infants with IL7RA deficiency can be identified through newborn screening program. We aimed at defining the immunological and genetic parameters that are directly affected by the IL7RA mutation on the immune system of five unrelated patients which were identified by our newborn screening program for SCID. The patients were found to have a novel identical homozygote mutation in IL7RA (n.c.120 C>G; p.F40L). Both surface expression of IL7Rα and functionality of IL-7 signaling were impaired in patients compared to controls. Structural modeling demonstrated instability of the protein structure due to the mutation. Lastly the TRG immune repertoire of the patients showed reduced diversity, increased clonality and differential CDR3 characteristics. Interestingly, the patients displayed significant different clinical outcome with two displaying severe clinical picture of immunodeficiency and three had spontaneous recovery. Our data supports that the presented IL7RA mutation affects the IL-7 signaling and shaping of the TRG repertoire, reinforcing the role of IL7RA in the immune system, while non-genetic factors may exist that attribute to the ultimate clinical presentation and disease progression.
topic IIL7Rα
PID
SCID
NBS
TREC
immune repertoire
url https://www.frontiersin.org/article/10.3389/fimmu.2019.01672/full
work_keys_str_mv AT atarlev reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT atarlev reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT amosjsimon reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT amosjsimon reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT ortalbarel reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT ortalbarel reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT eraneyal reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT eraneyal reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT eraneyal reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT efratglicksaar reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT efratglicksaar reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT efratglicksaar reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT omrinayshool reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT omrinayshool reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT omrinayshool reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT ohadbirk reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT talistauber reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT amithochberg reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT arnonbroides reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT shlomoalmashanu reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT ayalhendel reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT yuneelee reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT yuneelee reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT razsomech reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
AT razsomech reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation
_version_ 1724868627659751424
spelling doaj-f599f85fc3684f1b96df701ade6f8c092020-11-25T02:20:57ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-07-011010.3389/fimmu.2019.01672469112Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA MutationAtar Lev0Atar Lev1Amos J. Simon2Amos J. Simon3Ortal Barel4Ortal Barel5Eran Eyal6Eran Eyal7Eran Eyal8Efrat Glick-Saar9Efrat Glick-Saar10Efrat Glick-Saar11Omri Nayshool12Omri Nayshool13Omri Nayshool14Ohad Birk15Tali Stauber16Amit Hochberg17Arnon Broides18Shlomo Almashanu19Ayal Hendel20Yu Nee Lee21Yu Nee Lee22Raz Somech23Raz Somech24The National Lab for Diagnosing SCID - The Israeli Newborn Screening Program, Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Sheba Medical Center, Edmond and Lily Safra Children's Hospital, Israel Ministry of Health, Tel HaShomer, IsraelThe Mina and Everard Goodman Faculty of Life Sciences, Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat-Gan, IsraelSheba Cancer Research Center and Institute of Hematology, Sheba Medical Center, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelSheba Cancer Research Center and Institute of Hematology, Sheba Medical Center, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelSheba Cancer Research Center and Institute of Hematology, Sheba Medical Center, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Wohl Institute for Translational Medicine, Sheba Medical Center, Tel HaShomer, IsraelSheba Cancer Research Center and Institute of Hematology, Sheba Medical Center, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Wohl Institute for Translational Medicine, Sheba Medical Center, Tel HaShomer, IsraelSheba Cancer Research Center and Institute of Hematology, Sheba Medical Center, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Wohl Institute for Translational Medicine, Sheba Medical Center, Tel HaShomer, IsraelSoroka Medical Center, Genetics Institute, The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, IsraelThe National Lab for Diagnosing SCID - The Israeli Newborn Screening Program, Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Sheba Medical Center, Edmond and Lily Safra Children's Hospital, Israel Ministry of Health, Tel HaShomer, IsraelDepartment of Pediatrics, Hillel Yaffe Medical Center, Hadera, IsraelFaculty of Health Sciences, Soroka University Medical Center, Pediatric Immunology Clinic, Ben-Gurion University of the Negev, Beer Sheva, IsraelThe National Center for Newborn Screening, Israel Ministry of Health, Tel HaShomer, IsraelThe Mina and Everard Goodman Faculty of Life Sciences, Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat-Gan, IsraelThe National Lab for Diagnosing SCID - The Israeli Newborn Screening Program, Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Sheba Medical Center, Edmond and Lily Safra Children's Hospital, Israel Ministry of Health, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe National Lab for Diagnosing SCID - The Israeli Newborn Screening Program, Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Sheba Medical Center, Edmond and Lily Safra Children's Hospital, Israel Ministry of Health, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe alpha subunit of IL-7 receptor (IL7R7α) is critical for the differentiation of T cells, specifically for the development and maintenance of γδT cells. Mutations in IL7RA are associated with Severe Combined Immunodeficiency (SCID). Infants with IL7RA deficiency can be identified through newborn screening program. We aimed at defining the immunological and genetic parameters that are directly affected by the IL7RA mutation on the immune system of five unrelated patients which were identified by our newborn screening program for SCID. The patients were found to have a novel identical homozygote mutation in IL7RA (n.c.120 C>G; p.F40L). Both surface expression of IL7Rα and functionality of IL-7 signaling were impaired in patients compared to controls. Structural modeling demonstrated instability of the protein structure due to the mutation. Lastly the TRG immune repertoire of the patients showed reduced diversity, increased clonality and differential CDR3 characteristics. Interestingly, the patients displayed significant different clinical outcome with two displaying severe clinical picture of immunodeficiency and three had spontaneous recovery. Our data supports that the presented IL7RA mutation affects the IL-7 signaling and shaping of the TRG repertoire, reinforcing the role of IL7RA in the immune system, while non-genetic factors may exist that attribute to the ultimate clinical presentation and disease progression.https://www.frontiersin.org/article/10.3389/fimmu.2019.01672/fullIIL7RαPIDSCIDNBSTRECimmune repertoire